Altisource Residential Corporation Announces Quarterly Cash Dividend
Sep 19, 2017 20:50 pm UTC| Business
CHRISTIANSTED, U.S. Virgin Islands, Sept. 19, 2017 -- Altisource Residential Corporation (“RESI”) (NYSE:RESI) announced today that its Board of Directors has declared a quarterly cash dividend of $0.15 per share of...
Sep 19, 2017 20:47 pm UTC| Business
LOS ANGELES, Sept. 19, 2017 -- Lundin Law PC, a shareholder rights firm, announces a class action lawsuit against Tableau Software, Inc. (“Tableau” or the “Company”) (NYSE:DATA) for possible violations of federal...
Krystal Biotech Announces Pricing of Upsized Initial Public Offering
Sep 19, 2017 20:46 pm UTC| Business
PITTSBURGH, Pa., Sept. 19, 2017 -- Krystal Biotech, Inc. (“Krystal”), a gene therapy company dedicated to developing and commercializing novel treatments for patients suffering from dermatological diseases, today...
Noront Resources Closing of Private Placement of Flow-Through Shares
Sep 19, 2017 20:46 pm UTC| Business
(Previously released on Friday, September 15, 2017) TORONTO, Sept. 19, 2017 -- Noront Resources Ltd. (“Noront”) (TSX Venture:NOT) announced on Friday September 15, 2017 the closing of a private placement of 9,239,000...
Vornado Provides Information Regarding its Investment in Toys “R” Us
Sep 19, 2017 20:40 pm UTC| Business
NEW YORK, Sept. 19, 2017 -- VORNADO REALTY TRUST (NYSE:VNO) announced that Toys “R” Us (“Toys”) yesterday filed a voluntary petition under Chapter 11 of the U.S. Bankruptcy Code. Vornado had previously fully reserved...
Sep 19, 2017 20:39 pm UTC| Business
LIVERMORE, Calif., Sept. 19, 2017 -- FormFactor, Inc. (NASDAQ:FORM), an industry-leading electrical test and measurement supplier to the semiconductor industry, announced the release of the SmartMatrix 1500XP probe card...
Iovance Biotherapeutics, Inc. Announces Public Offering of Common Stock
Sep 19, 2017 20:35 pm UTC| Business
SAN CARLOS, Calif., Sept. 19, 2017 -- Iovance Biotherapeutics, Inc. (NASDAQ:IOVA), a biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) technology, today announced...